Thrombotic complications in patients with PMM2-CDG

Molecular Genetics and Metabolism

Volumn 109, Issue 1, 2013, Pages 107-111

  Linssen, M ^a   Mohamed, M ^a   Wevers, R A ^a   Lefeber, D J ^a   Morava, E ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AT III; CDG; Coagulation factors; Glycosylation; Surgery; Thrombosis

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 9; PROTEIN C; PROTEIN S;

ARTERY THROMBOSIS; ARTICLE; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1A; FAMILY HISTORY; GENE MUTATION; GLYCOSYLATION; HEMOSTASIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; SYSTEMATIC REVIEW; THROMBOSIS; VEIN THROMBOSIS;

ANTITHROMBIN III; BLOOD COAGULATION; CLINICAL TRIALS AS TOPIC; CONGENITAL DISORDERS OF GLYCOSYLATION; HUMANS; PROTEIN C; PROTEIN S; THROMBOSIS;

EID: 84876085700     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.02.006     Document Type: Article

References (26)

1. Jaeken J. Congenital disorders of glycosylation. Ann. N. Y. Acad. Sci. 2010, 1214:190-198.
2. Grünewald S. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim. Biophys. Acta 2009, 1792:827-834.
3. Arnoux J.B., Boddaert N., Valayannopoulos V., Romano S., Bahi-Buisson N., et al. Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia. Mol. Genet. Metab. 2008, 93:444-449.
4. Van Geet C., Jaeken J., Freson K., Lenaerts T., Arnout J., Vermylen J., Hoylaerts M.F. A unique pattern of coagulation abnormalities in carbohydrate-deficient glycoprotein syndrome. J. Inherit. Metab. Dis. 1993, 24:813-820.
5. Fiumara A., Barone R., Buttitta P., Musso R., Pavone L., Nigro F., Jaeken J. Haemostatic studies in carbohydrate-deficient glycoprotein syndrome type I. Thromb. Haemost. 1996, 76:502-504.
6. Böhles H., Sewell A.A., Gebhardt B., Reinecke-Lüthge A., Klöppel G., Marquardt T.S. Hyperinsulinaemic hypoglycaemia-leading symptom in a patient with congenital disorder of glycosylation Ia (phosphomannomutase deficiency). J. Inherit. Metab. Dis. 2001, 24:858-862.
7. Truin G., Guillard M.C., Lefeber D.J., Sykut-Cegielska J., Adamowicz M., et al. Pericardial and abdominal fluid accumulation in congenital disorder of glycosylation type Ia. Mol. Genet. Metab. 2008, 94:481-484.
8. Parveen Kumar & Michael Clark, M. C. Clinical Medicine. Saunders (2009) Elsevier. 8th Edition.
9. Clark Michael L., Parveen Kumar Thrombosis in infants and children. Hematology 2006, 86-96.
10. Ishikawa N., Tajima G., Ono H., Kobayashi M. Different neuroradiological findings during two stroke-like episodes in a patient with a congenital disorder of glycosylation type Ia. Brain Dev. 2009, 31:240-243.
11. Blank C., Smith L.A., Hammer D.A., Fehrenbach M., et al. Recurrent infections and immunological dysfunction in congenital disorder of glycosylation Ia (CDG Ia). J. Inherit. Metab. Dis. 2006, 29:592.
12. Pérez-Dueñas B., García-Cazorla A., Pineda M., et al. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations. Eur. J. Paediatr. Neurol. 2009, 13:444-451.
13. Romano S., Bajolle F., Valayannopoulos V., et al. Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia). J. Med. Genet. 2009, 46:287-288.
14. Barone R., Sturiale L., Sofia V., et al. Clinical phenotype correlates to glycoprotein phenotype in a sib pair with CDG-Ia. Am. J. Med. Genet. A 2008, 146A:2103-2108.
15. Wurm D., Löffler G., Lindinger A., Gortner L. Congenital disorders of glycosylation type Ia as a cause of mirror syndrome. J. Perinatol. 2007, 27:802-804.
16. Vermeer S., Kremer H.P., Leijten Q.H., et al. Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening. J. Neurol. 2007, 254:1356-1358.
17. Krasnewich D., O'Brien K., Sparks S. Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia). Am. J. Med. Genet. C Semin. Med. Genet. 2007, 145C:302-306.
18. van de Kamp J.M., Lefeber D.J., Ruijter G.J., et al. Congenital disorder of glycosylation type Ia presenting with hydrops fetalis. J. Med. Genet. 2007, 44:277-280.
19. Wurm D., Hänsgen A., Kim Y.J., Lindinger A., Baghai A., Gortner L. Early fatal course in siblings with CDG-Ia (caused by two novel mutations in the PMM2 gene): clinical, molecular and autopsy findings. Eur. J. Pediatr. 2007, 166:377-378.
20. Funk M., Becker S., Pötzsch B., Kreuz W., Böhles H. Thrombophilia in a child with CDG-syndrome type I. Thromb. Haemost. 1995, 74:1199-1200.
21. Iijima K., Murakami F., Nakamura K., et al. Hemostatic studies in patients with carbohydrate-deficient glycoprotein syndrome. Thromb. Res. 1994, 76:193-198.
22. Westphal V., Enns G.M., McCracken M.F., et al. Functional analysis of novel mutations in a congenital disorder of glycosylation Ia patient with mixed Asian ancestry. Mol. Genet. Metab. 2001, 73:71-76.
23. Kjaergaard S., Schwartz M., Skovby F. Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype. Arch. Dis. Child. 2001, 85:236-239.
24. Miossec-Chauvet E., Mikaeloff Y., Heron D., et al. Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia. Neuropediatrics 2003, 34:1-6.
25. Damen G., de Klerk H., Huijmans J., et al. Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic. J. Pediatr. Gastroenterol. Nutr. 2004, 38:282-287.
26. Schollen E., Keldermans L., Foulquier F., et al. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients. Mol. Genet. Metab. 2007, 90:408-413.